HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM)

被引:733
作者
BUTLER, MA
IWASAKI, M
GUENGERICH, FP
KADLUBAR, FF
机构
[1] NATL CTR TOXICOL RES,DIV BIOCHEM TOXICOL,HFT-110,JEFFERSON,AR 72079
[2] UNIV ARKANSAS,DEPT PHARMACOL & TOXIKOL,LITTLE ROCK,AR 72205
[3] VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232
[4] VANDERBILT UNIV,MED CTR,SCH MED,CTR MOLEC TOXICOL,NASHVILLE,TN 37232
关键词
D O I
10.1073/pnas.86.20.7696
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:7696 / 7700
页数:5
相关论文
共 51 条
[1]   STIMULATION OF CAFFEINE METABOLISM IN RAT BY 3-METHYLCHOLANTHRENE [J].
ALDRIDGE, A ;
PARSONS, WD ;
NEIMS, AH .
LIFE SCIENCES, 1977, 21 (07) :967-974
[2]   [2-C-14] CAFFEINE METABOLISM IN CONTROL AND 3-METHYL-CHOLANTHRENE INDUCED RAT-LIVER MICROSOMES BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
BONATI, M ;
LATINI, R ;
MARZI, E ;
CANTONI, R ;
BELVEDERE, G .
TOXICOLOGY LETTERS, 1980, 7 (01) :1-7
[3]   CAFFEINE DISPOSITION AFTER ORAL DOSES [J].
BONATI, M ;
LATINI, R ;
GALLETTI, F ;
YOUNG, JF ;
TOGNONI, G ;
GARATTINI, S .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (01) :98-106
[4]  
BUENING MK, 1981, CANCER RES, V41, P67
[5]  
BUTLER MA, 1989, CANCER RES, V49, P25
[6]  
CAMPBELL ME, 1987, DRUG METAB DISPOS, V15, P237
[7]   A URINARY METABOLITE RATIO THAT REFLECTS SYSTEMIC CAFFEINE CLEARANCE [J].
CAMPBELL, ME ;
SPIELBERG, SP ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (02) :157-165
[8]  
CONNEY AH, 1976, CLIN PHARMACOL THER, V20, P633
[9]   THE CONTRIBUTION OF GENETICALLY-DETERMINED OXIDATION STATUS TO INTERINDIVIDUAL VARIATION IN PHENACETIN DISPOSITION [J].
DEVONSHIRE, HW ;
KONG, I ;
COOPER, M ;
SLOAN, TP ;
IDLE, JR ;
SMITH, RL .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) :157-166
[10]  
DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057